Cardiovascular and Metabolic Comorbidities of Psoriasis
- Corresponding Author:
- Ayman Elgendy
Department of Dermatology
Benha University, Egypt
E-mail: [email protected]
Received: December 19, 2015; Accepted: January 20, 2016; Published: January 22, 2016
Citation: Elgendy A, Alshawadfy E, Altaweel A, Elsaidi A (2016) Cardiovascular and Metabolic Comorbidities of Psoriasis. Dermatol Case Rep 1:106. doi:10.4172/dmcr.1000106
Copyright: © 2016 Elgendy A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Once considered to be solely a cutaneous disease, there is now robust evidence that psoriasis is associated with systemic inflammation and a significantly increased risk of cardio vascular disease (CVD). Moderate to severe psoriasis is associated with a higher incidence of cardiovascular risk factors such as diabetes mellitus, obesity, smoking, and the metabolic syndrome. It is now well established that patients with severe psoriasis have an excess mortality compared with the general population.